期刊文献+

冠状动脉支架内再狭窄发生机制的研究进展 被引量:39

Advances in the mechanism of restenosis after percutaneous coronary intervention
下载PDF
导出
摘要 经皮冠状动脉介入术是目前治疗冠状动脉粥样硬化性心脏病的主要有效的治疗手段,血管支架尤其是药物洗脱支架极大程度上改善了冠心病患者的疗效和预后。与支架相关的病理主要表现为支架内再狭窄引起的进行性心绞痛和支架内血栓导致的急性心肌梗死。支架内再狭窄是由生物、机械、技术及与患者自身相关的复杂相互作用介导形成的病理性新生内膜增生,有关其发病机制的研究正不断深入。本文通过血管内皮损伤、血管平滑肌细胞增殖迁移、血管外基质重构、炎症反应以及新生动脉内膜粥样硬化等方面对其进行综述,深入探讨其形成的影响因素及临床意义。 Percutaneous coronary intervention is one of the main means for the treatment of coronary heart disease(CAD);especially drug-eluting stent has been greatly improved the effect and prognosis of the CAD patients.Stent-related pathology is mainly manifested by in-stent restenosis(ISR)and in-stent thrombosis.ISR,a pathologic response to injury is due to the complex interaction of biological,mechanical,technological and patient-related factors.Its pathogenesis has been studied deeply in these years.In this report,we review the mechanism of ISR in different aspects and discuss its influencing factors and clinicial significance.
作者 王聪霞 贾珊 WANG Cong-xia;JIA Sha(Department of Cardiology,the Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an 710004,China)
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2018年第3期303-309,共7页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家自然科学基金资助项目(No.81273878)~~
关键词 经皮冠状动脉介入术 药物洗脱支架 支架内再狭窄 新生内膜增生 新生动脉粥样硬化斑块 percutaneous coronary intervention drug-eluting stent in-stent restenosis neointima hyperplasia neoatherosclerosis
  • 相关文献

参考文献1

二级参考文献20

  • 1张燕,黎莉,谭红伟,马志勇,王颖,李静.白细胞介素18与急性冠脉综合征的临床研究[J].临床医药实践,2005,14(1):9-11. 被引量:2
  • 2王绍欣,董平栓,杨旭明,李转珍,杨喜山,汪砚雨,李志娟,阎鹏.急性冠状动脉综合征患者冠状动脉血及外周血血浆基质金属蛋白酶-9水平检测[J].郑州大学学报(医学版),2006,41(6):1092-1094. 被引量:4
  • 3UDDIN SN,MALIK F,BARI MA,et al.Angiographic severity and extent of coronary artery disease in patients with type 2diabetes mellitus[J].Mymensingh Med J,2005,14(1):32-37.
  • 4KATAOKA Y,YASUDA S,MORII I,et al.Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance[J].Diabetes Care,2005,28(12):2217-2222.
  • 5SUZUKI H,KUSUYAMA T,SATO R,et al.Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction[J].Eur J Clin Invest,2008,38(3):166-173.
  • 6PRESTA I,ANDREOZZI F,SUCCURRO E,et al.IL-18 gene polymorphism and metabolic syndrome[J].Nutr Metab Cardiovasc Dis,2009,19(2):e5-e6.
  • 7ESPOSITO K,MARFELLA R,GIUGLIANO D.Plasma interleukin-18 concentrations are elevated in type 2 diabetes[J].Diabetes Care,2004,27(1):272.
  • 8FIOTTI N,ALTAMUR N,ORLANDO C,et al.Metalloproteinases-2,-9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI[J].Int J Cardiol,2008,127(3):350-357.
  • 9UEMURA S,RUPPRECHT HJ,POIRIER O,et al.Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease[J].Circulation,2003,107(4):1579-1585.
  • 10KISHIMOTO C,HIRATA M,HAMA K,et al.Carotid intima media thickness is increased in subjects with ischemic heart disease having a familial incidence[J].Exp Clin Cardol,2006,11(1):8-10.

共引文献12

同被引文献410

引证文献39

二级引证文献225

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部